Found: 8
Select item for more details and to access through your institution.
Living Health Technology Assessment: Issues, Challenges and Opportunities.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 3, p. 227, doi. 10.1007/s40273-022-01229-4
- By:
- Publication type:
- Article
Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 3, p. 239, doi. 10.1007/s40273-023-01244-z
- By:
- Publication type:
- Article
Impact of Influenza and Influenza-Like Illness on Work Productivity Outcomes: A Systematic Literature Review.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 3, p. 253, doi. 10.1007/s40273-022-01224-9
- By:
- Publication type:
- Article
Caregiver Burden of Spinal Muscular Atrophy: A Systematic Review.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 3, p. 275, doi. 10.1007/s40273-022-01197-9
- By:
- Publication type:
- Article
Whether and How Disutilities of Adverse Events were Used in the Economic Evaluation of Drug Therapy for Cancer Treatment.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 3, p. 295, doi. 10.1007/s40273-022-01232-9
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of a New Second-Line Treatment Regimen for Advanced Intrahepatic Cholangiocarcinoma: Biomarker-Driven Targeted Therapy of Pemigatinib Versus 5-FU Chemotherapy.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 3, p. 307, doi. 10.1007/s40273-022-01227-6
- By:
- Publication type:
- Article
Incorporating Dynamic Pricing in Cost-Effectiveness Analysis: Are Known Unknowns Valuable?
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 3, p. 321, doi. 10.1007/s40273-022-01230-x
- By:
- Publication type:
- Article
The Egyptian EQ-5D-5L Extensive Pilot Study: Lessons Learned.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 3, p. 329, doi. 10.1007/s40273-022-01208-9
- By:
- Publication type:
- Article